NEWS
FDA Accepts File for German Biopharmaceutical Company’s Multiple Sclerosis Pill
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that a resubmission of the New Drug Application (NDA) for cladribine tablets as a potential treatment for patients […]